A Multicentre Randomised Trial Of Etanercept And Methotrexate To Induce Remission In Early Inflammatory Arthritis.

Trial Profile

A Multicentre Randomised Trial Of Etanercept And Methotrexate To Induce Remission In Early Inflammatory Arthritis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Jan 2012

At a glance

  • Drugs Etanercept (Primary) ; Methotrexate
  • Indications Arthritis; Synovitis
  • Focus Therapeutic Use
  • Acronyms EMPIRE
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 19 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 11 Jan 2012 New source identified and integrated (ISRCTN: Current Controlled Trials; ISRCTN55428162).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top